Schedule 13G ownership disclosure
Olema Pharmaceuticals Inc
Security class unavailable · CUSIP: 68062P106
Event date: 2023-03-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-043619
- Form type
- SC 13G
- Filer
- Olema Pharmaceuticals, Inc.
- CIK
- CIK 1750284
- Filed
- Apr 10, 2023
- Reporting period
- Mar 29, 2023
- Description
- Schedule 13G beneficial ownership